Status:
COMPLETED
Characterization of Intestinal Microbiota Stability in Preterm Born Neonates
Lead Sponsor:
Emma Marie Caroline Slack
Collaborating Sponsors:
University of Zurich
University Children's Hospital, Zurich
Conditions:
Necrotising Enterocolitis
Late-Onset Neonatal Sepsis
Eligibility:
All Genders
Up to 3 years
Brief Summary
Study around very-low birthweight preterm infants at high risk of developing necrotizing enterocolitis (NEC) or late-onset sepsis (LOS). Collection of stool and other biological samples to assess the ...
Detailed Description
This study aims to collect biological samples (stool, stomach fluid, and blood) from preterm infants at risk of developing NEC or LOS; as well as environmental samples from infants' hospital surroundi...
Eligibility Criteria
Inclusion
- Preterm infants with a gestational age \< 32 weeks or a birthweight \< 1500g and their family members
Exclusion
- Intestinal atresia
- Live born infants referred to from other hospitals later than 3 days after birth
Key Trial Info
Start Date :
February 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 20 2023
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT04792918
Start Date
February 11 2021
End Date
June 20 2023
Last Update
July 10 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Children's Hospital Zürich
Zurich, Switzerland, 8032
2
University Hospital Zürich
Zurich, Switzerland, 8091